Han, Jinming
Chitu, Violeta
Stanley, E. Richard
Wszolek, Zbigniew K.
Karrenbauer, Virginija Danylaité http://orcid.org/0000-0002-7166-8951
Harris, Robert A.
Funding for this research was provided by:
Neuroforbundet
National Cancer Institute (P30CA013330 NCI Cancer Center Grant, P30CA013330)
Intellectual and Developmental Disabilities Research Center (U54 HD090260 support for the Rose F. Kennedy, U54 HD090260)
Foundation for the National Institutes of Health (Grant R01NS091519)
David and Ruth Levine Fund
the Haworth Family Professorship in Neurodegenerative Diseases Fund
The Sol Goldman Charitable Trust
Mayo Clinic Center for Regenerative Medicine
The Albertson Parkinson’s Research Foundation
the Donald G. and Jodi P. Heeringa Family
Stockholms Läns Landsting
Biogen
Novartis
Merck
Medicinska Forskningsrådet
Alltid Lite Sterkere
Alzheimerfonden
Hjärnfonden
Barncancerfonden
Karolinska Institute
Article History
Received: 6 December 2021
Revised: 6 February 2022
Accepted: 26 February 2022
First Online: 2 April 2022
Declarations
:
: ZKW serves as PI or Co-PI on Biogen, Inc. (228PD201), Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301), and Neuraly, Inc. (NLY01-PD-1) grants. He serves as Co-PI of the Mayo Clinic APDA Center for Advanced Research. VDK Biogen (recipient of grant and scholarship, PI for project sponsored by); Novartis (Scientific Advisory board member, recipient of scholarship and lecture honoraria); Merc (Scientific Advisory Board member, recipient of lecture honoraria), Neuro Vigil (Scientific Advisory Board member). VDK has received financial support from Stockholm County Council (Grant ALF 20160457), Biogen (recipient of grant and scholarship, PI for the project sponsored by Biogen); Novartis (Scientific Advisory Board member, recipient of scholarship and lecture honoraria) and Merck (Scientific Advisory Board member, recipient of lecture honoraria).
: Not applicable.
: Not applicable.